Description: - A unique collection of 400 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.- Contains antifungal agents to treat tinea corporis and Candidiasis, and compounds inhibiting the fungal-specific targets.- Bioactivity and safety confirmed by clinical research and trials, some of which are FDA approved;- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;- Structurally diverse, medicinally active, and cell permeable;Structurally diverse, medicinally active, and cell permeable;- NMR and HPLC validated to ensure high purity and quality;